Advertisement

Alcon Laboratories issues a warning on certain intraocular lenses after finding a higher-than expected rate of accelerated endothelial cell loss.

Alcon Labs logo

Alcon Laboratories in conjunction with Australian healthcare regulators issued a warning on certain intraocular lenses after receiving reports of higher-than-expected rates of accelerated endothelial cell loss.

Alcon warned that a 5-year study of its AcrySof Cachet Phakic Lenses uncovered that about 1 in 100 required removal as a result of ECL, with higher rates in patients with smaller eyes or who self-identified as being Asian.

Advertisement
Advertisement